These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26708594)

  • 1. Molecular Mechanisms of Bone Metastasis.
    Weidle UH; Birzele F; Kollmorgen G; Rüger R
    Cancer Genomics Proteomics; 2016; 13(1):1-12. PubMed ID: 26708594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dickkopf-1 as a mediator and novel target in malignant bone disease.
    Rachner TD; Göbel A; Benad-Mehner P; Hofbauer LC; Rauner M
    Cancer Lett; 2014 May; 346(2):172-7. PubMed ID: 24462802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of tumor metastasis to the bone: challenges and opportunities.
    Reddi AH; Roodman D; Freeman C; Mohla S
    J Bone Miner Res; 2003 Feb; 18(2):190-4. PubMed ID: 12568395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer.
    Quayle L; Ottewell PD; Holen I
    Curr Cancer Drug Targets; 2015; 15(6):469-80. PubMed ID: 25968899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
    Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
    FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bone microenvironment invigorates metastatic seeds for further dissemination.
    Zhang W; Bado IL; Hu J; Wan YW; Wu L; Wang H; Gao Y; Jeong HH; Xu Z; Hao X; Lege BM; Al-Ouran R; Li L; Li J; Yu L; Singh S; Lo HC; Niu M; Liu J; Jiang W; Li Y; Wong STC; Cheng C; Liu Z; Zhang XH
    Cell; 2021 Apr; 184(9):2471-2486.e20. PubMed ID: 33878291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local effects of malignancy on bone.
    Brown SA; Clines GA; Guise TA
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):436-41. PubMed ID: 17982348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour but not stromal expression of β3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer.
    Carter RZ; Micocci KC; Natoli A; Redvers RP; Paquet-Fifield S; Martin AC; Denoyer D; Ling X; Kim SH; Tomasin R; Selistre-de-Araújo H; Anderson RL; Pouliot N
    J Pathol; 2015 Apr; 235(5):760-72. PubMed ID: 25430721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
    Ibrahim A; Scher N; Williams G; Sridhara R; Li N; Chen G; Leighton J; Booth B; Gobburu JV; Rahman A; Hsieh Y; Wood R; Vause D; Pazdur R
    Clin Cancer Res; 2003 Jul; 9(7):2394-9. PubMed ID: 12855610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidence.
    Awolaran O; Brooks SA; Lavender V
    Breast; 2016 Dec; 30():156-171. PubMed ID: 27750106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative role of acetylation along c-SRC/ETS1 signaling pathway in bone metastatic and invasive mammary cell phenotypes.
    Bendinelli P; Maroni P; Matteucci E; Desiderio MA
    Biochim Biophys Acta; 2011 Oct; 1813(10):1767-76. PubMed ID: 21741415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour dormancy in inflammatory microenvironment: A promising therapeutic strategy for cancer-related bone metastasis.
    Hu W; Zhang L; Dong Y; Tian Z; Chen Y; Dong S
    Cell Mol Life Sci; 2020 Dec; 77(24):5149-5169. PubMed ID: 32556373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular signature of breast cancer metastasis to bone.
    Bahrami T; Mokmeli S; Hossieni H; Pourpaknia R; Makani Z; Salmaninejad A; Estiar MA; Hossieni A; Farshbaf A
    Anticancer Drugs; 2016 Oct; 27(9):824-31. PubMed ID: 27384592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone metastases in breast cancer, prostate cancer and myeloma.
    Paterson AH
    Bone; 1987; 8 Suppl 1():S17-22. PubMed ID: 3318889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine aspects of bone metastases.
    Hofbauer LC; Rachner TD; Coleman RE; Jakob F
    Lancet Diabetes Endocrinol; 2014 Jun; 2(6):500-12. PubMed ID: 24880565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers.
    Midavaine É; Côté J; Sarret P
    Cancer Metastasis Rev; 2021 Jun; 40(2):427-445. PubMed ID: 33973098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis.
    Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R
    Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.